Matching Adjusted Indirect Comparisons of Personalized Prophylaxis with Simoctocog Alfa Versus Efmoroctocog Alfa, Damoctocog Alfa Pegol and Rurioctocog Alfa Pegol in Patients with Hemophilia a

被引：0
|
作者：
Kessler, Craig M. [1 ]
Tiede, Andreas [2 ]
机构：
[1] Georgetown Univ, Sch Med, Washington, DC USA
[2] Hannover Med Sch, Clin Haematol Haemostaseol Oncol & Stem Cell Tran, Hannover, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162205
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2755 / 2756
页数：2
相关论文
共 50 条
  • [1] Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A
    Vashi, Parth
    Batt, Katharine
    Klamroth, Robert
    Mancuso, Maria Elisa
    Majewska, Renata
    Tiede, Andreas
    Mantovani, Lorenzo Giovanni
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 935 - 943
  • [2] Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a
    Kessler, Craig
    Corrales-Medina, Fernando F.
    Mannucci, Pier Mannuccio
    Tarantino, Michael D.
    BLOOD, 2023, 142
  • [3] PHARMACOKINETIC ANALYSIS IN PATIENTS WITH HEMOPHILIA A SEVERE IN PROPHYLAXIS WITH RURIOCTOCOG ALFA PEGOL
    Lopez-Jaime, F. -J.
    Diaz-Aizpun, C.
    Martin-Tellez, S.
    Doblas-Marquez, A.
    Munoz-Lopez, F. -D.
    Perez-Raya, M.
    Mena-Santano, A. -M.
    HAEMOPHILIA, 2021, 27 : 106 - 107
  • [4] Damoctocog Alfa Pegol for Hemophilia A Prophylaxis: An Italian Multicenter Survey
    Zanon, Ezio
    PHARMACEUTICALS, 2023, 16 (09)
  • [5] Damoctocog Alfa Pegol: A Review in Haemophilia A
    Julia Paik
    Emma D. Deeks
    Drugs, 2019, 79 : 1147 - 1156
  • [6] Personalised prophylaxis with simoctocog alfa versus standard prophylaxis with efanesoctocog alfa in haemophilia A, a matching-adjusted indirect comparison
    Kessler, C. M.
    Corrales-Medina, F. F.
    MannuccioMannucci, P.
    Astermark, J.
    Tarantino, M. D.
    HAEMOPHILIA, 2024, 30 : 54 - 55
  • [7] Damoctocog Alfa Pegol: A Review in Haemophilia A
    Paik, Julia
    Deeks, Emma D.
    DRUGS, 2019, 79 (10) : 1147 - 1156
  • [8] Effectiveness of Damoctocog Alfa Pegol to Treat Patients With Hemophilia A Enrolled in the ATHNdataset
    Chandler, Martin
    Moulton, Thomas
    Charafi, Lena
    Charlet, Jessica
    Recht, Michael
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (03) : 448 - 457
  • [9] Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a
    Kessler, Craig
    Corrales-Medina, Fernando F.
    Mannucci, Pier Mannuccio
    Tarantino, Michael D.
    BLOOD, 2023, 142
  • [10] Potency-Adjusted Analyses of a Head-to-Head Pharmacokinetic Study of Damoctocog Alfa Pegol (BAY 94-9027) and Efmoroctocog Alfa (rFVIIIFc) in Patients with Severe Hemophilia A
    Solms, Alexander
    Shah, Anita
    Wiegmann, Sara
    Ahsman, Maurice
    Berntorp, Erik
    Tiede, Andreas
    Iorio, Alfonso
    Mancuso, Maria Elisa
    Zhivkov, Tihomir
    Lissitchkov, Toshko
    BLOOD, 2020, 136
12345